Case Reports in Ophthalmology is an esteemed peer-reviewed journal published by KARGER, dedicated to advancing the field of ophthalmology through the dissemination of high-quality case reports. Since its establishment in 2010, the journal has maintained its Open Access model, ensuring that valuable research is accessible to a global audience, thus fostering collaboration and innovation in eye care. Hailing from Switzerland, the journal covers a broad range of topics within ophthalmology, providing a platform for clinicians and researchers to share unique clinical insights and pivotal findings. With a current impact factor that positions it within the Q3 category of ophthalmology in the 2023 rankings, Case Reports in Ophthalmology is a vital resource for professionals seeking to stay abreast of emerging trends and case studies in the field. Researchers and students alike will benefit from its rigorous peer-review process and its commitment to supporting quality research initiatives, making it an essential addition to any ophthalmology library.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

Ophthalmic and Physiological Optics, published by Wiley, is a premier peer-reviewed journal dedicated to advancing the fields of ophthalmology, optometry, and sensory systems. With an impressive impact factor and categorized in the prestigious Q1 quartile for 2023 across multiple disciplines, the journal provides a vital platform for researchers and practitioners to disseminate innovative findings and explore the complexities of visual science. Founded in 1981, it continues to thrive as a leading resource for reviewing contemporary issues, emerging technologies, and clinical practices. Readers will benefit from its rigorous editorial standards and access to groundbreaking studies pertinent to both academic and clinical environments. Situated at the forefront of the discipline, Ophthalmic and Physiological Optics plays an essential role in bridging the gap between research and practical application, ensuring a comprehensive understanding of vision and its physiological underpinnings.

CORNEA is a prestigious peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the rapidly advancing field of ophthalmology with a particular emphasis on corneal research and diseases. With an impact factor categorized in the prestigious Q1 quartile for its discipline, CORNEA has established itself as a leading platform for the dissemination of both fundamental and clinical studies since its inception in 1982. The journal is ranked 25th out of 137 in the Scopus Medicine-Ophthalmology category, placing it in the 82nd percentile among its peers, which underscores its vital role in influencing ocular research and clinical practices. While the journal is not currently open access, it provides valuable insights and updates for professionals, researchers, and students working to advance knowledge in corneal health, contributing significantly to the ongoing dialogue in the ophthalmological community. With a commitment to excellence, CORNEA continues to publish high-quality research and reviews in its pursuit to improve ocular outcomes and patient care.

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

JOURNAL FRANCAIS D OPHTALMOLOGIE, published by MASSON EDITEUR, is a prominent peer-reviewed journal that serves as a vital resource in the field of ophthalmology. Launched in 1978, this esteemed publication continues to make significant contributions to the advancement of ocular health and vision science, with its scope encompassing clinical practices, innovative research, and the latest technological advancements in ophthalmic care. Based in France, the journal is recognized in the 2023 category quartiles with a Q3 ranking in ophthalmology, reflecting its dedication to quality scholarship within a competitive landscape, as evidenced by its positioning in the 30th percentile of the Scopus rankings. While it operates without Open Access, the journal remains crucial for professionals, researchers, and students alike, providing a platform for sharing knowledge and fostering collaborations in the global ophthalmological community.

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

The Middle East African Journal of Ophthalmology is a distinguished publication dedicated to advancing knowledge in the field of ophthalmology, published by Wolters Kluwer Medknow Publications in India. With a robust focus on contributions that bridge the gap between clinical practices and scientific research, this journal serves as a crucial platform for researchers, practitioners, and students alike. Since its inception, it has consistently disseminated high-impact research, achieving notable recognition with a Q3 ranking in both Medicine (miscellaneous) and Ophthalmology categories as of 2023. Despite being a newer entrant into the scholarly landscape, it features an array of innovative articles, highlighting significant advancements and emerging trends in ocular health. Researchers may access a wealth of knowledge through its open access articles, promoting the dissemination of vital ophthalmic research that is relevant in both Middle Eastern and African contexts. By fostering collaboration and communication among professionals in the field, the Middle East African Journal of Ophthalmology is committed to championing excellence in eye care and elevating the standard of research applicable to global populations.

Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.